World Trade Factory™

Pfizer Sues Metsera to Block Novo Nordisk’s $9B “Bribe” Deal

Pfizer Sues Metsera to Block Novo Nordisk’s $9B “Bribe” Deal

In a dramatic escalation of a high-stakes biopharma showdown, Pfizer Inc. has filed suit in Delaware Chancery Court to stop Metsera from backing out of their multibillion-dollar merger, accusing Novo Nordisk of orchestrating an “old-fashioned bribe” to derail the deal and crush future competition in the booming weight-loss drug market. Pfizer’s lawsuit, filed Friday—the same Pfizer Sues Metsera to block $9B Novo Nordisk offer, calling it an “old-fashioned bribe” attempt.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.